Second-line glucose-lowering therapies are initiated too late

Who needs to know?

Patients with T2DM

Results

Many patients with type 2 diabetes mellitus (T2DM) have very high glycated haemoglobin (HbA1c) levels when initiating second-line therapy, indicating the need for earlier treatment intensification